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The awareness of Listeria monocytogenes as a pathogen in meningitis and bacteremia in immunosuppressed patients is high. We
report a case of vascular graft infection due to Listeria monocytogenes as an example of a less well-known manifestation of
listeriosis and focus on the possible treatment procedures emphasizing a management with surgical debridement but preservation
of the endograft, in contrast to the gold standard treatment of vascular graft infections which consists of a removal of the graft.
1.Introduction
The awareness of Listeria monocytogenes as a pathogen
in meningitis in immunosuppressed or elderly patients is
high. Also gastroenteritis, infections in pregnancy or sepsis
in neonates are well-known clinical manifestations due to
Listeria. However, this pathogen can cause many other
types of infection. As an example, we report here the so-
far 8th case of vascular graft infection due to Listeria,
where in general organisms like Staphylococci, E. coli, or
Streptococci are found. Our aim is to increase the awareness
of Listeria as a pathogen causing other clinical syndromes
in immunosuppressed patients over and above meningitis
and gastroenteritis, and we focus on the treatment options
in prosthetic graft infection due to Listeria reviewing the so
far reported 7 cases.
2. CasePresentation.
A 59-year-old man was referred to our hospital in August
2007 because of a progression of his chronic low back pain
which began at the beginning of May 2007 accompanied by
recurrent episodes of fever. The fever occured a few weeks
later at the end of May 2007, and because of a temperature of
39◦C the general practitioner treated the patient empirically
with a 10-day course of amoxicillin/clavulanate. After that,
the fever disappeared for a few weeks, but new episodes of
fever and pain attacks occurred in July and August 2007.
During this time, the C-reactive protein level was rising to
250mg/l at admission (standard value <5mg/l). The patient
was under immunosuppression with Ciclosporine A and
Mycophenolate-Mofetile after renal transplantation 2004,
and he got an endovascular repair of an infrarenal aortic
aneurysm with a Talent-graft in 2005. At admission, the
patient’slowbackpainandﬂuctuatingfeverwereinterpreted
as a sacroileitis. A MRI-scan showed no skeletal pathology
but a slight enhancement of the sclerotic infrarenal aorta
including an enhancement of the periaortal tissue. So, a
CT guided translumbar needle aspiration of the enhancing
structure was taken, and the cultures yielded growth of
Listeria monocytogenes, whereas the blood cultures remained
negative. Therefore, the patient was treated with ampicillin
2gm q4h intravenously without gentamicin because of his
impaired renal function (see Figure 1).
Under this antibiotic treatment, the CRP-level sank ini-
tially, but remained then around 120mg/l so that gentamicin
1mg/kgi.v.threetimesadaywasadded.Atthistime,thesur-
geon refused a surgical approach since the renal transplant
was vasculated through the graft and a removal of the graft
would have been a high risk for the transplanted organ. After
6 weeks of combined antibiotic therapy a new MRI showed
new collections around the vascular graft down to the psoas
muscle. A drainage delivered pure pus, the cultures were2 Case Reports in Medicine
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Figure 1: Sagital view of preoperative MRI-scan showing a
retroaortal ﬂuid collection with slight enhancement reaching to the
dorsal part of the prosthetic endograft.
sterile but an in-house eubacterial PCR (16S ribosomal DNA
sequenceanalysis)waspositiveforListeria.Soafter2months
of conservative treatment a surgical approach was faced due
to lacking improvement. Intraoperatively extensive inﬂam-
matory adhesions were found; therefore, the aneurysm with
the endograft could not be removed. Only a debridement
around the aneurysm and in the psoas muscle could be
performed. The Mycophenolate-Mofetil dosing was reduced
at that time. Two weeks thereafter and after 8 weeks of com-
binedintravenousantibiotictherapythepatientcouldbedis-
charged with an oral regimen consisting of 320mg trimetho-
prim/1600mg sulfamethoxazole twice a day. A MRI-scan 6
months later in June 2008 showed no more abscesses but
a slight enhancement in the periaortic tissue as well as in
the psoas muscle. In January 2009, the CRP achieved a
normal level (<5mg/l), and, in July 2009, there was no more
enhancement in the MRI-scan. Nevertheless, we decided to
continue the antibiotic treatment for another 2 years (until
July 2011) since the patient has a stable function of his renal
transplant and since a relapse of the graft infection would be
disastrous for the whole situation of the patient. In March
2011, the patient is well without any symptoms.
3. Discussion
A prosthetic graft infection is a very rare (0.6% to 3%)
but serious complication after aneurysm repair with a high
mortality (25% to 88%) [8–10]. Although there are no
guidelines, the gold standard in treatment consists of a
complete excision of the graft, reconstruction of an extra-
anatomic bypass, and an antibiotic treatment for several
weeks [8, 11]. Generally, organisms like Staphylococci or
gramnegative enteric organisms as E. coli are responsible
for prosthetic graft infections [9]. Graft infections due to
Listeria are extremely rare. Including our case, only 8 cases
have been reported [1–7]. In general, Listeria monocytogenes
is an uncommon cause of severe illness. Healthy hosts may
develop self-limited febrile gastroenteritis, whereas patients
with risk factors are prone for invasive disease. Risk factors
are the extremes of age (neonates and elderly persons >60
years), pregnancy, and especially impaired cellular immunity
asinorgantransplantrecipientsorpatientswithhematologic
malignancies [12]. According to that, ﬁve of the eight
vascular graft infections due to Listeria occurred in patients
showing at least one of the reported risk factors like age
(case no. 1, 6, 7) or immunosuppression (case no. 3, 8) (see
Table 1). Our case is the only case of Listerial graft infection
in a solid organ transplanted patient.
In the 8 analysed cases, with one exception, the mean
interval between graft implantation and onset of infection
was 2 years (range 12 weeks to 10 years), indicating a
hematogeneous spread of infection. Listeria occur ubiq-
uitous are mainly ingested with contaminated food, and
invasive disease evolves by hematogeneous spread from the
gut [13]. 1–5% of healthy individuals are asymptomatic
intestinal carriers of Listeria [12]. This was presumably also
the way our patient achieved the graft infection, but it was
not possible to determine the source where he ingested
Listeria. He did not report having eaten raw milk or soft
cheese nor did he purchase food from delicatessen counters
regularly.Asachemist,hedidnothaveanyriskbyprofession
like, for example, farmers who are in direct contact to cattle
which are possible carriers of Listeria as well. Only 5% of all
casesofListeriosisoccurinoutbreaks.InSwitzerland,thelast
outbreak was in 2005 [14] but in an area far from where
the patient lived. Apart from his immunosuppression due
to the renal transplantation, our patient did not have any
further risk factors for Listeriosis as for example described
by Fern` andez-Seb´ e et al. [15] for solid-organ transplant
recipients: no diabetes mellitus, no history of CMV-disease,
or high-dose steroid therapy in the preceding 6 months. As
r e p o r t e db yS t a m me ta l .[ 16], Listeriosis in renal transplant
recipients in particular occured in 75% during the ﬁrst year
after transplantation. In our case, the manifestation of the
infection was 4 years after transplantation, but the moment
of acquisition remains unclear.
The diagnosis of graft infections can be extremely
challenging. Symptoms are often nonspeciﬁc like recurrent
fever and chills or back pain as it was in our case. With
a sensitivity of 94% and a speciﬁcity of 85% CT-scan is
considered the diagnostic test of choice [8, 9], but since it
cannot distinguish sterile ﬂuid from perigraft abscedation,
PET/CT seems to be a promising method. Blood cultures
are only positive in 21%, cultures of drain production or of
the prosthesis itself in 50% [8]. Considering the 8 reported
cases with Listerial graft infections blood cultures were taken
in only 5 of the 8 patients and were positive in three of
the ﬁve. An aspirate of the perigraft ﬂuid was taken in 6 of
the cases, and all of the samples showed growth of listeria.
This fact points out that culturing perigraft ﬂuid seems toCase Reports in Medicine 3
Table 1: Summary of the 8 so-far reported graft infections due to Listeria monocytogenes.
No RF BC Foc Early surgery Follow up Antibiotics Ref
1A g e ( 7 5 y ) N D +
Removal of
Gore-Tex
prosthesis,
thrombectomy
of dacron
cross-over graft
After 3 weeks:
death from
pneumonia
Amox/clavulanic acid
i.v. + Gm i.m. [1]
2H D N D +
Partial removal
of graft, PTFE
graft
interposition
After 3 months:
recurrence with
sepsis → shunt
removal,
antibiotic
therapy not
described
CTX 3 × 1g i.v. 2d;
then Amp 4 × 1gi.v .
7d; then Amp 4 ×
500mg p.o. 4d
[2]
3
Steroids +
Azathio-
prine for
several
months
+N D N D N o n e
Amp iv 6 × 2g4
weeks; then STX po 4
weeks
[3]
4 None + ND ND
7 weeks after stop
antibiotics:
recurrence,
conservative
treatment
Amp 4 × 2g i.v. 19d
+G m1× 80mg i.v.
4d Recurrence:A m p6
× 2g i.v. 6 weeks +
Gm 240mg i.v. 4
weeks; then Amox 3
× 1gpo8weeks
[4]
5H D , D M ++ N D
2 weeks after stop
Vanco: relapse
→ graft and
abscess removal
Vanco 750mg/wk for
3w e e k sRelapse: Amp
i.v. 3 weeks
[5]
6A g e ( 7 7 y ) − +N D
After 2 weeks of
persistence:
resection of
aneurysm
Amp iv 6 × 2g+Net
1 × 300mg 2
weeks After resection:
Amp 6 × 2gi.v .for6
weeks; then Doxy
150mg for 4 weeks
[6]
7 Age (67y),
DM ND + ND
Later:
percutaneous
drainage
Amox-clavulanic acid
i.v. + STX 800/160
3/d, then STX 6
months
[7]
8 Trspl (Age
59y)
− +N D
After 6 weeks:
percutaneous
drainage and
surgical
debridement
Amp 6 × 2g+Gm
1mg/kg i.v. tid for 6
weeks; After
debridement:A m p6
× 2g+Gm1mg/kg
i.v. tid for 2 weeks;
then STX for 4 years
Tanner
Amox: amoxicillin; Amp, ampicillin; BC: blood cultures; CTX: cefotaxime; DM: diabetes mellitus; Foc: cultures of focus; Gm: gentamicin; HD: hemodialysis,
Net: netilmicin; ND: not done; PTFE: polytetraﬂuoroethylene; RF: risk factors; SXT trimethoprim-sulfamethoxazole; tid: 3 times a day; Tobra: trobramycin;
Trspl: transplanation; Vanco: vancomycin.
have a considerably higher sensitivity compared to the 50%
reported by Saleem et al. [8].
With regard to the treatment strategy, persistence or
recurrence of the infection was observed in both with (case
no.2)andwithout(casesno.4–8)initialremovalofthepros-
thesis (see Table 1), where at the gold standard of treatment
consists of an early removal of the graft. Antibiotic therapy
alone was initially tried in 6 of the 8 cases, but was successful
in only two patients (cases no. 3, 4). In one case a percu-
taneous drainage was ﬁnally successful (no. 7), and in our
case (no. 8), a surgical debridement without graft removal
was successful in the end (see Table 1). So, we conclude and
agree with Saleem et al. [7, 8] that in patients with a high
perioperative risk, a preservation of the endograft together4 Case Reports in Medicine
with a prolonged and high-dose antimicrobial therapy com-
binedwithradiologicaldrainageorsurgicaldebridementbut
without graft removal is a possible treatment option.
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